23/10/2009 (Agence Europe) - Erring on the side of caution, the European Medicines Agency has decided that for the time being, the clinical data provided by the laboratories, to conclude that a single dose of vaccination against A(H1N1)v influenza would be adequate, is insufficient. Pending complimentary data, it is sticking to its initial recommendation of two injections at a three-week interval. The EMEA acknowledges, however, that the initial data indicate that in the case of two...